心力衰竭治疗的目标：循证管理。
Targeting success in heart failure: evidence-based management.
机构信息
Department of Academic Family Medicine, University of Saskatchewan, Regina.
出版信息
Can Fam Physician. 2010 Dec;56(12):1313-7.
Abstract
Heart failure (HF) is a common condition in primary care with 1% of the population self-reporting this condition. Mortality is substantial, approaching 40% to 50% over 5 years. Heart failure is a complex syndrome in which abnormal heart function results in, or increases the subsequent risk of, clinical symptoms and signs of low cardiac output or pulmonary or systemic congestion.¹ This article will present some practical tips for managing HF.²
摘要
心力衰竭（HF）是基层医疗中常见的病症，有 1%的人群自我报告患有这种疾病。死亡率相当高，5 年内接近 40%至 50%。心力衰竭是一种复杂的综合征，其中异常的心脏功能导致或增加了临床低心输出量或肺或全身充血的症状和体征的风险。¹本文将介绍一些管理心力衰竭的实用技巧。²
相似文献
1
Targeting success in heart failure: evidence-based management.心力衰竭治疗的目标：循证管理。
Can Fam Physician. 2010 Dec;56(12):1313-7.
2
Heart failure: an overview of consensus guidelines and nursing implications.心力衰竭：共识指南概述及护理要点
Can J Cardiovasc Nurs. 2003;13(2):30-4.
3
Managing patients with heart failure.
Am J Nurs. 2001 Dec;101(12):34-40. doi: 10.1097/00000446-200112000-00018.
4
Heart failure: highlights from new consensus guidelines.
Cleve Clin J Med. 2000 Jan;67(1):13-6. doi: 10.3949/ccjm.67.1.13.
5
[Heart failure. 2: Therapy].[心力衰竭。2：治疗]
Praxis (Bern 1994). 2010 Jan 20;99(2):83-91; quiz 92-3. doi: 10.1024/1661-8157/a000030.
6
How well are chronic heart failure patients being managed?慢性心力衰竭患者的管理情况如何？
Rev Cardiovasc Med. 2006;7 Suppl 1:S3-11.
7
Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.在肺动脉压力监测期间与心力衰竭住院减少相关的干预措施。
JACC Heart Fail. 2016 May;4(5):333-44. doi: 10.1016/j.jchf.2015.11.011. Epub 2016 Feb 10.
8
[Management of heart failure].[心力衰竭的管理]
Soins. 2013 Apr(774):29-34.
9
The ABCs of managing systolic heart failure: Past, present, and future.管理收缩性心力衰竭的 ABC 法则：过去、现在和未来。
Cleve Clin J Med. 2016 Oct;83(10):753-765. doi: 10.3949/ccjm.83a.16006.
10
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.患者对心力衰竭药物治疗的认知与熟悉程度
JAMA Cardiol. 2020 Mar 1;5(3):292-299. doi: 10.1001/jamacardio.2019.4987.
本文引用的文献
1
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.慢性心力衰竭患者运动训练的疗效与安全性：HF-ACTION随机对照试验
JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454.
2
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.β受体阻滞剂继续使用或停用对心力衰竭住院患者预后的影响：OPTIMIZE-HF项目的研究结果
J Am Coll Cardiol. 2008 Jul 15;52(3):190-9. doi: 10.1016/j.jacc.2008.03.048.
3
Telmisartan, ramipril, or both in patients at high risk for vascular events.替米沙坦、雷米普利或两者联合用于血管事件高危患者。
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
4
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.加拿大心血管学会2007年心力衰竭最新共识会议建议：预防、并发疾病或急性失代偿期间的管理以及生物标志物的应用。
Can J Cardiol. 2007 Jan;23(1):21-45. doi: 10.1016/s0828-282x(07)70211-8.
5
Pre-dosing metolazone with loop diuretic combination regimens.在使用袢利尿剂联合方案前给予美托拉宗。
Nephrol Nurs J. 2006 Jan-Feb;33(1):78-9.
6
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.2006年加拿大心血管学会关于心力衰竭的共识会议建议：诊断与管理
Can J Cardiol. 2006 Jan;22(1):23-45. doi: 10.1016/s0828-282x(06)70237-9.
7
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.慢性心力衰竭中的血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂
Ann Intern Med. 2005 Mar 1;142(5):388; author reply 388-9. doi: 10.7326/0003-4819-142-5-200503010-00019.
8
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.硝酸异山梨酯与肼苯哒嗪联合用于黑人心力衰竭患者
N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.
9
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.坎地沙坦对不能耐受血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM替代试验
Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5.
10
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.坎地沙坦对正在服用血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM-Added试验
Lancet. 2003 Sep 6;362(9386):767-71. doi: 10.1016/S0140-6736(03)14283-3.
Zotero 插件